Patents/Assignees

GENMAB A/S

23 patents in portfolio

US11608383utility2023
Bispecific Antibody Against CD3 and CD20 in Combination Therapy for Treating Follicular Lymphoma
0 cites
US11578141utility2023
Bispecific Antibodies Against HER2 and CD3
0 cites
US11548952utility2023
Bispecific Antibody Against CD3 and CD20 in Combination Therapy for Treating Diffuse Large B-cell Lymphoma
0 cites

← PreviousPage 2 of 2